02380 408 600 Contact us Book a course

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Menu

×

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.

Post navigation

Previous: Specialist Cohort Event Monitoring Studies: a New Study Method in Risk Management in Pharmacovigilance

Next: Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa® (testosterone patch).

Interested in conducting a study?

Get in touch today to discuss your requirements

Services

Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training

Information

Publications
DSRU News
Press
General Practitioners
Conference Abstracts

Organisation

About Us
Meet The Team
Job Vacancies
Privacy Policy
Terms & Conditions

© 2023 DSRU - Bursledon Hall, Blundell Lane, Southampton, SO31 1AA | Registered Charity No. 327206 | Designed & developed by Dolia